All Research on Medical Devices and Diagnostics in Italy

Insight

Report
Report

Hot Topics: Impact of Biomarkers in Alzheimer's Disease - Dx-Rx collaboration paves the way for personalized medicine

Qualitative and quantitative assessment of how biomarkers can change the diagnostic and commercial landscape in Alzheimer’s disease. The analysis provides an outline of the opportunities for drug and diagnostics companies in the Alzheimer’s market.

Published By Datamonitor
$2800
Buy

Profiles

Company Profile
Company Profile

Menarini Group, The

The Menarini Group (Menarini or 'the group'), a privately-held pharmaceutical business entity, is engaged in the development and manufacture of pharmaceutical products mainly for cardiovascular diseases, oncology, and pain, inflammation and asthma. The group primarily operates in Italy. It is headquartered in Florence, Italy and employed 16,603 people at the end of the year 2013.

Published By MarketLine
$175
Buy

No help is available.